e-learning
resources
Vienna 2003
Monday 29.09.2003
Cystic fibrosis: modern methods of monitoring the disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Longitudinal follow-up of pulmonary, nutritional and laboratory data in patients with cystic fibrosis related diabetes mellitus (CFRD) after initial treatment with glibenclamid
M. Ballmann, C. Mueller-Brandes (Hannover, Germany)
Source:
Annual Congress 2003 - Cystic fibrosis: modern methods of monitoring the disease
Session:
Cystic fibrosis: modern methods of monitoring the disease
Session type:
Poster Discussion
Number:
1535
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Ballmann, C. Mueller-Brandes (Hannover, Germany). Longitudinal follow-up of pulmonary, nutritional and laboratory data in patients with cystic fibrosis related diabetes mellitus (CFRD) after initial treatment with glibenclamid. Eur Respir J 2003; 22: Suppl. 45, 1535
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Muscle energy techniques for COPD patients: Effects on pulmonary function and activities of daily living
Related content which might interest you:
The association of pulmonary fibrosis with diabetes mellitus
Source: ERJ Open Res, 6 (4) 00237-2020; 10.1183/23120541.00237-2020
Year: 2020
Role of BMI in the clinical course of COPD patients with type 2 diabetes mellitus
Source: International Congress 2018 – COPD and extrapulmonary comorbidities
Year: 2018
Clinical features of pulmonary tuberculosis in patients with diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012
Impact of diabetes mellitus on pulmonary tuberculosis clinical presentation and treatment outcomes
Source: International Congress 2018 – Tuberculosis comorbidities
Year: 2018
Treatment effectiveness among patients with newly detected pulmonary tuberculosis with diabetes mellitus comorbidity
Source: Eur Respir J 2004; 24: Suppl. 48, 653s
Year: 2004
Radiological features of pulmonary tuberculosis in patients with diabetes mellitus
Source: Annual Congress 2011 - Management of tuberculosis
Year: 2011
Improving identification and treatment of children & adolescents with cystic fibrosis related diabetes (CFRD)
Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Year: 2012
Newly detected pulmonary tuberculosis in patients combined with diabetes mellitus and without it.
Source: International Congress 2019 – Tuberculosis and comorbidities
Year: 2019
Is there any characteristics difference between pulmonary tuberculosis patients with and without diabetes mellitus type 2?
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009
Study of pulmonary function in type2 diabetes mellitus and its changes with change in duration and glycemic control
Source: Annual Congress 2012 - Pathophysiological mechanisms in disease: new insights
Year: 2012
Peculiarities of diabetes mellitus in cystic fibrosis adults
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010
Late Breaking Abstract - The cost, health resources utilization and medications in chronic obstructive pulmonary patients with diabetes mellitus: a population-based cohort study in Taiwan.
Source: International Congress 2019 – COPD treatment: cardiovascular, oxygen and vaccination studies
Year: 2019
Effect of ICS on glycaemic control in patients with COPD and comorbid type 2 diabetes: Historical case-matched cohort study
Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care
Year: 2016
Presentations and treatment response of pulmonary tuberculosis in type 2 diabetes mellitus
Source: Annual Congress 2012 - Tuberculosis: clinical findings II
Year: 2012
Intensive chemotherapy of pulmonary tuberculosis in patients with diabetes mellitus
Source: Eur Respir J 2004; 24: Suppl. 48, 648s
Year: 2004
New criteria for impaired fasting glucose and screening for diabetes in cystic fibrosis
Source: Eur Respir J 2005; 25: 715-717
Year: 2005
To improvement of diagnostics of the diabetes mellitus 2 type at patients with chronic obstructive pathology of lungs
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Decline of the lung function and quality of glycemic control in type 2 diabetes mellitus
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Increased augmentation index in patients with cystic fibrosis
Source: Eur Respir J 2009; 34: 1322-1328
Year: 2009
Impact of diabetes mellitus on clinical parameters and treatment outcomes of diagnosed pulmonary tuberculosis patients
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept